
The Government’s Chief Scientific Adviser Sir Patrick Vallance has said that 60% of people being admitted to hospital with COVID-19 …

US state attorneys general are set to unveil a $26 billion settlement this week, aimed at three major drug distributors …

Researchers have identified a gene, IFI27, that becomes activated in early stages of COVID-19 even when symptoms are absent, helping …

Brits were temporarily unable to order lateral flow COVID-19 test kits on ‘Freedom Day’, the day nearly all restrictions in …

China has approved AstraZeneca’s drug Imfinzi to treat an aggressive type of lung cancer in adults. The drug’s use with …

Apollon Formularies have announced its medical cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate …

The UK government has announced the launch of 15 new extensive studies, backed by £19.6 million in funding, to investigate …

Some children are to be offered COVID-19 vaccines ahead of winter in the UK. The Vaccines Minister Nadhim Zahawi told …

The charity Breast Cancer Now has launched a petition calling on Gilead to provide free-of-charge access to its new treatment …

Pfizer has reached a $345 million settlement over consumer claims they overpaid for EpiPens as a result of unfair, anticompetitive …

The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma …

Young adults admitted to hospital with COVID-19 are almost as likely to experience complications as those over 50, a study …

China-based biotech HUTCHMED has announced that the EMA has validated and accepted the Marketing Authorisation Application (MAA) for surufatinib, for …

The Royal College of Obstetricians and Gynaecologists (RCOG) and the Royal College of Midwives (RCM) have expressed fears over the …

Incyte and Novartis have announced the publication of positive data from Phase III trials in NEJM, demonstrating Jakavi (ruxolitinib) significantly …

The MHRA has issued an Early Access to Medicines Scheme (EAMS) positive scientific opinion for tepotinib, for the treatment of …

A report from the Academy of Medical Sciences has found that a lethal triple mix of COVID-19, influenza, and the …

CARMAT has announced that the first ever human implantation of their fully artificial heart, which was designed as a therapeutic …

The US government has started a review process for national Medicare coverage of Biogen’s controversial Alzheimer’s drug, Aduhelm, that was …

An Israeli study looking at those who have contracted COVID following double vaccination with the Pfizer jab, has found that …